ES | EN | PT
ISSN 2604-7071

Rapidly embolizing intraventricular thrombus formation in dilated cardiomyopathy due to late cardiotoxicity during oligosymptomatic SARCOV-2

Bouzas Cruz, Noelia

Cardio-oncology and Covid-19 are two increasingly topical pathologies. A frequent form of the former is non-ischemic dilated cardiomyopathy, which, like coronavirus infection, is associated with a risk of increased interventricular thrombi. Such thrombi are a potentially fatal problem whose management has not yet been studied in depth, forcing the clinician on many occasions to make decisions without quality evidence to support them ...


Heart failure with improved ejection fraction: case report

González Lozano, Jaime

We have presented the case of a 54-year-old man with heart failure, severe left ventricular hypertrophy and initially depressed systolic function that later normalizes. This patient and his pathology have been chosen due to its high frequency in clinical practice, its complexity, atypical evolution, and wide differential diagnosis ...


Differential diagnosis and therapeutic approach of de-novo heart failure

Calvo Barceló, María

A 56-year-old-male without medical history apart from severe alcohol consumption was admitted due to de-novo heart failure. Echocardiography showed severe biventricular dysfunction and severe mitral regurgitation, as well as atrial fibrillation. He was diagnosed from dilated cardiomyopathy of probable mixed aetiology ...


A rare cause of acute heart failure

Jordán Martínez, Laura

Systemic lupus erythematosus is a systemic autoimmune disease mediated by immune complexes that induce complement activation and systemic inflammation. A rare manifestation, although possible, is myocardial injury, which is a diagnostic, therapeutic, and prognostic challenge ...


Impact of the use of empagliflozin in a patient with advanced heart failure with preserved ejection fraction and extravascular congestion

Mas Maresma, Laia

Heart failure is an increasingly prevalent disease with a high morbidity and mortality rate. In recent years, several disease-modifying drugs that improve this disease's prognosis and mortality rates have been released. Nevertheless, the benefits of these drugs have been mainly proven in heart failure with reduced ejection fraction ...


Heart failure is when the pieces of the puzzle don’t fit

González Manzanares, Rafael

High-output heart failure (HF) is a rare subtype of HF characterized by increased cardiac output and reduced systemic vascular resistance. We present the case of a 61-year-old female with high-output HF secondary to a renal arteriovenous malformation ...